These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing, reported early 2004-002903-34 Phänotypisierung und Genotypisierung von Cytochrom P450-Enzymen not-yet-due
Not reported 2004-004086-15 Comparison of nephrotoxic effects of the contrast dyes iodixanol (iso-osmolar, non-ionic, dimer) and ioversol (low-osmolar, non-ionic, monomer) in patients with impaired renal function and severe hear... 2006-12-31 due-trials
Reported results 2005-000968-33 Doppel-blinde, randomisierte, kontrollierte Studie zur intraarteriellen Transplantation von Knochenmarks-Progenitorzellen bei Patienten mit chronischer Ischämie bei pAVK (Intraarterial Progenitor Ce... 2010-03-31 due-trials
Reported results 2005-005709-50 Extracorporal shock wave therapy for induction of therapeutic neovascularization and homing of bone marrow progenitor cells in patients with chronic ischemic heart disease 2011-05-31 due-trials
Not reported 2006-000358-38 Individually adapted therapy duration from 24 to 72 weeks for the treatment of patients with a chronic hepatitis C genotype 1 infection with Peginterferon alfa-2b plus Ribavirin in dependence of the i... 2010-01-08 due-trials
Completed, but no date, and reported results Terminated 2006-000393-76 Allogenic stem cell transplantation with CD3/CD19 depleted stem cells from haploidentical related and non-related donators in pediatric patients with and without malignant systemic diseases. bad-data
Reported results Terminated 2006-006180-23 Einfluss einer Vitamin D-Substitution auf die Insulinresistenz, die Stoffwechseleinstellung und die Lymphozytenfunktion bei Patienten mit Typ 2 Diabetes mellitus 2008-06-30 due-trials
Reported results Terminated 2006-006384-24 Bestimmung der stimulierten ß-Zell-Kapazität im oralen Nateglinide 50 g Glukose-Toleranz-Test - „Nateglinide-Test“ 2008-06-30 due-trials
Ongoing 2007-001802-25 An exploratory, open label phase II study to evaluate the feasibility of contrast-enhanced MRI for measurement of perfusion in squamous cell cancer of the head & neck: comparison of the intravascular ... not-yet-due
Ongoing 2007-004222-24 Intra-individual, randomized comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem when imaging the pelvis in patients with spondylarthritides, evaluated in a blinded read not-yet-due
Ongoing 2007-004541-15 A Randomized Controlled Open-Label Phase IV Mono Center Study to Compare the Reponse Profiles of Montelukast versus Fluticason in Children with Preschool Asthma not-yet-due
Not reported 2007-004874-14 Doppel-blinde, randomisierte, kontrollierte Studie zur Erfassung des Effektes einer intrakoronaren Applikation von Knochenmark-Progenitorzellen auf die koronare Flußreserve bei Patienten mit akutem Ko... 2017-06-30 due-trials
Reported results 2007-006272-11 Validation of Dermatophot for the assessment of steroid induced skin atrophy 2011-11-30 due-trials
Completed, but no date, and reported results 2008-000654-12 PHARMACOKINETIC BERINERT P STUDY OF SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN SUBJECTS WITH MODERATE HEREDITARY ANGIOEDEMA - THE PASSION STUDY bad-data
Ongoing 2008-002278-37 Auswirkungen von Pantoprazol auf die myokardiale Kontraktilität bei Patienten mit Herzinsuffizienz - influence of pantoprazole on human myocardial contractility at patients with congestive heart failu... not-yet-due
Not reported Terminated 2008-007667-17 Doppelblinde, randomisierte Placebo-kontrollierte crossover-Studie zur Erfassung des Effektes einer DPP-IV-Hemmung auf die Zahl und Funktion von Progenitorzellen sowie die Endothelfunktion von Patient... 2013-03-22 due-trials
Reported results Terminated 2009-009909-25 Evaluation of the efficacy and safety of a Macugen monotherapy versus Combined Therapies in the Treatment of Diabetic Retinopathy – a single centre, randomized, prospective Phase II trial 2011-10-24 due-trials
Ongoing 2009-015739-34 Status of the growth hormone/ insulin-like growth factor-1 (GH/IGF-1) axis in relation to growth failure, body weight and neuroprotection in children with Ataxia telangiectasia (AT) not-yet-due
Reported results 2009-015950-39 Addition of Rituximab to Leflunomide in patients with active rheumatoid arthritis 2015-12-17 due-trials
Reported results 2010-018699-26 Phase I/II study with oral panobinostat maintenance therapy following allogeneic stem cell transplantation in patients with high risk MDS or AML (PANOBEST) 2020-06-19 due-trials
Exempt, with results 2010-021622-35 A monocenter, non-controlled, non-randomized IST to compare bioavailability of Kaletra softgelcapsules or -suspension to Kaletra tablets in pediatric patients – C2T Eine monozentrische, nicht kon... 2014-05-07 not-yet-due
Exempt, with results 2010-021624-99 A multi-centre, non-controlled, non-randomised IST to evaluate the plasma level of antiretroviral substances, the viral resistance profile and their impact on the clinical response in HIV infected ch... 2022-05-09 not-yet-due
Reported results Terminated 2010-022854-18 OPEN LABEL PHASE II STUDY TO EVALUATE THE SAFETY OF STANDARD INDUCTION AND CONSOLIDATION THERAPY IN COMBINATION WITH DASATINIB IN NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE ... 2015-09-30 due-trials
Reported results 2010-022855-46 AN OPEN LABEL PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INDUCTION AND CONSOLIDATION THERAPY WITH NILOTINIB IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS AGED 55 YEARS AND OVER WITH PHILADEL... 2020-03-10 due-trials
Other 2011-000595-33 Randomized controlled trial to compare the effects of single versus repeated intracoronary application of autologous bone marrow-derived mononuclear cells on total and SHFM-predicted mortality in pati... not-yet-due
Reported results 2011-002365-37 A double-blind, placebo-controlled, randomized, multicenter phase II trial to assess the efficacy of temsirolimus added to standard primary therapy in elderly patients with newly diagnosed AML 2017-04-26 due-trials
Completed, reported early 2011-006310-13 CAO/ARO/AIO-12: Induction chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: A randomized phase II trial of the German Rectal Cancer Study Grou... 2023-06-16 not-yet-due
Exempt 2012-001039-30 BetHäm2012: A monocenter, single-blind, randomized, 2-armed, placebo-controlled, cross-over study to investigate coagulation markers in patients with haemophilia A after administration of Betain ... not-yet-due
Exempt, with results 2012-001725-26 A Phase I/II Gene Therapy trial for X-CGD with a SIN gamma retroviral vector Phase I/II somatische Gentherapiestudie zur Behandlung der X-chromosomalen septischen Granulomatose 2019-09-11 not-yet-due
Not reported Terminated 2012-004082-41 Monocenter, double blind, randomised, placebo controlled study t evaluate Physostigmin for the Treatment of delirium in perioperative intensive care medicine Monozentrische, doppelblinde, randomisi... 2021-02-28 due-trials
Ongoing 2013-003466-13 Treatment optimization in adult patients with newly diagnosed acute lymphoblastic leukemia or lymphoblastic lymphoma by individualised, targeted and intensified treatment - a phase IV-trial with a pha... not-yet-due
Completed, report not yet due 2013-005446-11 A prospective phase I/II study to investigate the feasibility, safety and efficacy of IL-15 activated cytokine induced killer (CIK) cells in relapsing patients with acute leukemia or myelodysplastic s... 2023-07-21 not-yet-due
Completed, report not yet due 2015-000733-76 A multicenter, single-arm study to assess the efficacy, safety, and tolerability of the BiTE® antibody blinatumomab in adult patients with minimal residual disease (MRD) of B-precursor acute lympho-bl... 2023-07-31 not-yet-due
Reported results 2015-001820-51 BMC2012, Cell based therapy by implanted bone marrow-derived mononuclear cells (BMC) for bone augmentation of plate-stabilized proximal humeral fractures - a randomized, open, multicentric study - pha... 2020-01-07 due-trials
Ongoing 2015-004028-69 5-Fluorouracil (5-FU), folinic acid and irinotecan (FOLFIRI) versus 5-FU and folinic acid as second-line chemotherapy in patients with biliary tract cancer (IRIBIL): a randomized open-label phase 2 st... not-yet-due
Listed as ongoing, but also has a completion date 2016-000706-12 A Phase 2, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Standard of Care in Subjects with Previously Untreated and Advanced (unresectable or metastatic) non-clear Cell Ren... 2023-11-23 bad-data
Ongoing 2016-003568-38 German Treatment Optimization Study for Children with De Novo and Relapsed Langerhans cell Histiocytosis (LCH) as Part of the International Study LCH-IV not-yet-due
Reported results 2016-004488-38 Iluvit – An investigator initiated monocentric pilot study to investigate inflammation parameters and growth factors in the vitreous during a cortisone long-term therapy with Iluvien® in patients with... 2019-10-04 due-trials
Completed, but no date Terminated 2016-004836-39 An open label phase II study to evaluate the efficacy and safety of Inotuzumab Ozogamicin for Induction Therapy followed by a conventional chemotherapy based consolidation and maintenance therapy In p... bad-data
Not reported 2017-000435-13 Exploratory study to evaluate changes in inflammatory pattern and analysis for serum biomarkers in patients with active, moderate-to-severe hidradenitis suppurativa after 2-week and 6-week treatment w... 2020-03-03 due-trials
Ongoing 2017-000764-15 European Intergroup Trial on panobinostat maintenance after HSCT for high-risk AML and MDS - A randomized, multicenter phase III study to assess the efficacy of panobinostat maintenance therapy vs. st... not-yet-due
Completed, report not yet due 2017-002853-13 Phase II trial for the treatment of older patients with newly diagnosed CD19 positive, Ph/BCR-ABL negative B-precursor acute lymphoblastic leukemia with sequential dose reduced chemotherapy and Blinat... 2024-01-10 not-yet-due
Ongoing 2018-000876-14 ACO/ARO/AIO-18.1: Short-course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined intermediate and high-risk rectal cancer ... not-yet-due
Ongoing 2018-003005-25 Radiochemotherapy +/- Durvalumab for locally-advanced Anal Carcinoma A multicenter, randomized, phase II trial of the German Anal Cancer Study Group not-yet-due
Completed, report not yet due 2019-000922-23 Transarterial chemoembolization (TACE) with Irinotecan and Mitomycin C versus TACE with Doxorubicin in patients with Hepatocellular carcinoma not amenable to curative treatment - IRITACE- a randomized... 2023-11-22 not-yet-due
Reported results 2019-004491-19 A confirmatory multicenter, single-arm study to assess the efficacy, safety, and tolerability of ponatinib (Iclusig®) in adult patients with minimal residual disease (MRD) in Philadelphia-Chromosome p... 2023-03-10 due-trials
Ongoing 2019-004757-88 Additional chemotherapy for EGFRm patients with the continued presence of plasma ctDNA EGFRm at week 3 after start of osimertinib 1st-line treatment Zusätzliche Chemotherapie für Patienten mit EGFR... not-yet-due
Other 2021-000190-81 A prospective multicenter placebo-controlled trial to study the efficacy and safety of Tiotropium in preventing severe asthma exacerbations in partial and uncontrolled preschool asthma. TIPP-Study ... not-yet-due
Exempt 2021-001384-25 An open label, phase I/II study of Venetoclax in addition to Blinatumomab immunotherapy in adult patients with relapsed/refractory B cell precursor acute lymphoblastic leukemia (BCP-ALL) Eine off... not-yet-due
Ongoing 2021-001508-13 Randomized, controlled, double-blind trial to investigate the effect of colchicin on the endothelial function in patients with CHIP mutations and chronic heart failure with reduced left ventricular fu... not-yet-due
Ongoing 2022-001682-12 Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in patients with postacute inFLAMmatory cardiac involvEment due to COVID-19 (MYOFLAME-19) MYOFLAME-19 (Randomisiert... not-yet-due